『您的瀏覽器不支援JavaScript功能,若網頁功能無法正常使用時,請開啟瀏覽器JavaScript狀態』

跳到主要內容區塊

工業技術研究院

:::

新穎標靶青光眼藥物開發

技術簡介

 新穎標靶青光眼藥物開發。
新穎標靶青光眼藥物開發。

青光眼的罹患率正高倍速成長,已成為全球第二大的致盲因素,其用藥市場需求亦日益增加。然而,傳統青光眼藥方只能在有限選擇中輪迴使用,易衍生藥效疲乏與副作用。工研院長期深耕眼科小分子新藥研發,投入新機制青光眼標靶藥物,並進行專利群組布局、藥品臨床試驗申請及商業技轉。

特色與創新

工研院以自主研發之眼科標靶藥物開發技術作為核心平台,開發新一代青光眼ROCK(Rho-associated Kinase)抑制劑藥物,降眼壓藥效優於相關競品,且無明顯刺激副作用。

應用與效益

此技術吸引法國藥廠關注,展開進一步合作,將有助臺灣眼藥產業轉型。



[{"text":"企業網","weight":13.0},{"text":"材化所","weight":11.5},{"text":"機械所","weight":10.0},{"text":"綠能所","weight":9.4},{"text":"生醫所","weight":8.0},{"text":"半導體","weight":6.2},{"text":"南分院","weight":5.0},{"text":"太陽能","weight":5.0},{"text":"課程","weight":5.0},{"text":"遠紅外線","weight":5.0},{"text":"雷射","weight":4.0},{"text":"LED","weight":4.0},{"text":"LED可見光","weight":3.0},{"text":"5G","weight":3.0},{"text":"工研人","weight":3.0},{"text":"電光所","weight":3.0},{"text":"綠能與環境研究所","weight":3.0},{"text":"機械","weight":3.0},{"text":"資通所","weight":2.0},{"text":"面板","weight":2.0},{"text":"文字轉語音","weight":2.0},{"text":"實習","weight":2.0},{"text":"無人機","weight":2.0},{"text":"生醫","weight":2.0},{"text":"3D","weight":2.0},{"text":"v2x","weight":2.0},{"text":"員工","weight":2.0},{"text":"地圖","weight":2.0},{"text":"太陽光電","weight":2.0},{"text":"材料與化工研究所","weight":1.0}]